1
|
Páez-Avilés C, Juanola-Feliu E, Punter-Villagrasa J, Del Moral Zamora B, Homs-Corbera A, Colomer-Farrarons J, Miribel-Català PL, Samitier J. Combined Dielectrophoresis and Impedance Systems for Bacteria Analysis in Microfluidic On-Chip Platforms. SENSORS (BASEL, SWITZERLAND) 2016; 16:E1514. [PMID: 27649201 PMCID: PMC5038787 DOI: 10.3390/s16091514] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/23/2016] [Revised: 08/12/2016] [Accepted: 09/09/2016] [Indexed: 12/13/2022]
Abstract
Bacteria concentration and detection is time-consuming in regular microbiology procedures aimed to facilitate the detection and analysis of these cells at very low concentrations. Traditional methods are effective but often require several days to complete. This scenario results in low bioanalytical and diagnostic methodologies with associated increased costs and complexity. In recent years, the exploitation of the intrinsic electrical properties of cells has emerged as an appealing alternative approach for concentrating and detecting bacteria. The combination of dielectrophoresis (DEP) and impedance analysis (IA) in microfluidic on-chip platforms could be key to develop rapid, accurate, portable, simple-to-use and cost-effective microfluidic devices with a promising impact in medicine, public health, agricultural, food control and environmental areas. The present document reviews recent DEP and IA combined approaches and the latest relevant improvements focusing on bacteria concentration and detection, including selectivity, sensitivity, detection time, and conductivity variation enhancements. Furthermore, this review analyses future trends and challenges which need to be addressed in order to successfully commercialize these platforms resulting in an adequate social return of public-funded investments.
Collapse
Affiliation(s)
- Cristina Páez-Avilés
- Department of Electronics, Bioelectronics and Nanobioengineering Research Group (SIC-BIO), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain.
| | - Esteve Juanola-Feliu
- Department of Electronics, Bioelectronics and Nanobioengineering Research Group (SIC-BIO), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain.
| | - Jaime Punter-Villagrasa
- Department of Electronics, Bioelectronics and Nanobioengineering Research Group (SIC-BIO), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain.
| | - Beatriz Del Moral Zamora
- Department of Electronics, Bioelectronics and Nanobioengineering Research Group (SIC-BIO), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain.
| | - Antoni Homs-Corbera
- Department of Electronics, Bioelectronics and Nanobioengineering Research Group (SIC-BIO), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain.
- IBEC-Institute of Bioengineering of Catalonia, Nanobioengineering Research Group, Baldiri Reixac 10-12, 08028 Barcelona, Spain.
- CIBER-BBN-Biomedical Research Networking Centre for Bioengineering, Biomaterials and Nanomedicine, María de Luna 11, Edificio CEEI, 50018 Zaragoza, Spain.
| | - Jordi Colomer-Farrarons
- Department of Electronics, Bioelectronics and Nanobioengineering Research Group (SIC-BIO), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain.
| | - Pere Lluís Miribel-Català
- Department of Electronics, Bioelectronics and Nanobioengineering Research Group (SIC-BIO), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain.
| | - Josep Samitier
- Department of Electronics, Bioelectronics and Nanobioengineering Research Group (SIC-BIO), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain.
- IBEC-Institute of Bioengineering of Catalonia, Nanobioengineering Research Group, Baldiri Reixac 10-12, 08028 Barcelona, Spain.
- CIBER-BBN-Biomedical Research Networking Centre for Bioengineering, Biomaterials and Nanomedicine, María de Luna 11, Edificio CEEI, 50018 Zaragoza, Spain.
| |
Collapse
|
2
|
Abstract
Shiga toxin-producing Escherichia coli (STEC) is among the common causes of foodborne gastroenteritis. STEC is defined by the production of specific toxins, but within this pathotype there is a diverse group of organisms. This diversity has important consequences for understanding the pathogenesis of the organism, as well as for selecting the optimum strategy for diagnostic testing in the clinical laboratory. This review includes discussions of the mechanisms of pathogenesis, the range of manifestations of infection, and the several different methods of laboratory detection of Shiga toxin-producing E coli.
Collapse
|
3
|
Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 2013; 26:822-80. [PMID: 24092857 PMCID: PMC3811233 DOI: 10.1128/cmr.00022-13] [Citation(s) in RCA: 817] [Impact Index Per Article: 74.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Although Escherichia coli can be an innocuous resident of the gastrointestinal tract, it also has the pathogenic capacity to cause significant diarrheal and extraintestinal diseases. Pathogenic variants of E. coli (pathovars or pathotypes) cause much morbidity and mortality worldwide. Consequently, pathogenic E. coli is widely studied in humans, animals, food, and the environment. While there are many common features that these pathotypes employ to colonize the intestinal mucosa and cause disease, the course, onset, and complications vary significantly. Outbreaks are common in developed and developing countries, and they sometimes have fatal consequences. Many of these pathotypes are a major public health concern as they have low infectious doses and are transmitted through ubiquitous mediums, including food and water. The seriousness of pathogenic E. coli is exemplified by dedicated national and international surveillance programs that monitor and track outbreaks; unfortunately, this surveillance is often lacking in developing countries. While not all pathotypes carry the same public health profile, they all carry an enormous potential to cause disease and continue to present challenges to human health. This comprehensive review highlights recent advances in our understanding of the intestinal pathotypes of E. coli.
Collapse
|
4
|
Bavaro MF. E. coli O157:H7 and other toxigenic strains: the curse of global food distribution. Curr Gastroenterol Rep 2012; 14:317-323. [PMID: 22610457 DOI: 10.1007/s11894-012-0264-6] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
It is estimated that there are approximately 76 million illnesses, 325,000 hospitalizations, and 5,200 deaths in the US each year attributed to foodborne outbreaks with a total cost of 10-83 billion US dollars a year. While the rates of foodborne disease have remained relatively constant over the last few years, there have been large outbreaks associated with either a component of commercially prepared food or outbreaks that span between states or even countries. With the world population expecting fresh produce year round, organic produce, and exotic foods, these global outbreaks have the potential to increase in number and severity. There needs to be a means to both rapidly identify these outbreaks, screen our food supply, as well as prevent these outbreaks. This article will discuss the global nature of this problem associated with our food and water supply as well as explain potential ways to solve this international problem.
Collapse
Affiliation(s)
- Mary F Bavaro
- Infectious Diseases Division, Naval Medical Center San Diego, CA 92134, USA.
| |
Collapse
|
5
|
Bavaro MF. Escherichia coli O157: what every internist and gastroenterologist should know. Curr Gastroenterol Rep 2009; 11:301-306. [PMID: 19615306 DOI: 10.1007/s11894-009-0044-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Infections with Escherichia coli O157:H7 have gained media attention in recent years because of cases associated with unusual sources (eg, produce and swimming pools). Although most adults recover without sequelae, children and the elderly are more likely to develop complications (eg, hemolytic uremic syndrome and death). The diagnosis typically has been made by culture; however, newer hand-held immunoassays and polymerase chain reaction technology have led to more rapid detection of this important pathogen in stools, food, and water. Treatment is largely supportive; nonetheless, new methods to neutralize or bind toxin, such as probiotics, monoclonal antibodies, and recombinant bacteria, are showing promise to treat patients infected with E. coli O157:H7. The role of antibiotics in relation to this condition remains unclear.
Collapse
Affiliation(s)
- Mary F Bavaro
- Infectious Diseases Division, Naval Medical Center San Diego, 34800 Bob Wilson Drive, San Diego, CA 92134, USA.
| |
Collapse
|
6
|
Shelton DR, Karns JS, Park CH. A multiple protocol to improve diagnosis and isolation of Shiga toxin-producing Escherichia coli from human stool specimens. Diagn Microbiol Infect Dis 2008; 62:7-10. [PMID: 18550318 DOI: 10.1016/j.diagmicrobio.2008.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2007] [Revised: 04/25/2008] [Accepted: 05/01/2008] [Indexed: 10/22/2022]
Abstract
Many infections caused by Shiga toxin-producing Escherichia coli (STEC) are undiagnosed, particularly non-O157 STEC. We evaluated the use of a multiple protocol approach to improve diagnosis, isolation, and characterization of STEC strains. Among 18 presumptive STEC-positive stool samples received by the INOVA Fairfax Hospital, Falls Church, VA, in 2006, 16 were Shiga toxin positive. From these 16 stool samples, 8 O157:H7 and 5 non-O157 STEC were isolated by plating onto sorbitol MacConkey (SMAC) agar. The remaining 5 stool samples that did not yield colonies on SMAC agar plates were enriched. All enriched samples were Shiga toxin positive, and 2 O157:H7 and 1 non-O157 STEC were subsequently isolated. The 2 remaining enriched samples did not yield isolates; however, based on polymerase chain reaction (PCR) analysis, both samples contained STEC genes. Based on PCR analysis of non-O157 strains, 3 strain types were identified. Samples from 3 patients, received within 2 days of one another, had a similar gene profile-eae and stx(1) negative and stx(2) positive-suggesting that these patients were likely infected with the same strain. Our results indicate that a multiple protocol approach is necessary to reliably diagnose and isolate STEC strains, and that PCR profiling of strains could allow for more rapid identification of outbreaks.
Collapse
Affiliation(s)
- Daniel R Shelton
- Environmental Microbial Safety Laboratory, U.S. Department of Agriculture, Animal and Natural Resources Institute, Agricultural Research Service, Beltsville, MD, USA.
| | | | | |
Collapse
|
7
|
Chisholm SA, Watson CL, Teare EL, Saverymuttu S, Owen RJ. Non-invasive diagnosis of Helicobacter pylori infection in adult dyspeptic patients by stool antigen detection: does the rapid immunochromatography test provide a reliable alternative to conventional ELISA kits? J Med Microbiol 2004; 53:623-627. [PMID: 15184532 DOI: 10.1099/jmm.0.05502-0] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Stool antigen-testing allows non-invasive detection of Helicobacter pylori that is indicative of active infection. Three commercial kits are currently marketed in the UK for stool antigen-testing. The aim of this study was to conduct a comparative evaluation of the performances of each of these tests, compared with culture and histological examination of gastric biopsies, for pre-treatment diagnosis of infection in an adult dyspeptic population in south-east England. Examination of 112 stool samples by the Premier Platinum HpSA ELISA (Meridian Diagnostics) and by the Amplified IDEIA HpStAR ELISA (DakoCytomation) kits demonstrated that the latter was more sensitive (81.3 versus 93.8%, respectively) and specific (91.7 versus 100.0%, respectively). Additionally, the IDEIA HpStAR was easier to interpret, with OD readings of positive and negative results being far from the recommended cut-off, whereas equivocal results that were generated by the HpSA kit were difficult to interpret. Additional testing of 87 of the 112 stools by the ImmunoCard STAT! HpSA kit (Meridian Diagnostics) demonstrated that this test was easier to perform than ELISA and was more sensitive than the HpSA kit but, compared with the IDEIA HpStAR kit, the ImmunoCard test was less sensitive (87.8 versus 95.9%, respectively) and specific (89.4 versus 100.0%, respectively). Furthermore, the ImmunoCard test generated weakly positive results, correlating with lower OD readings for both ELISA kits, that were difficult to interpret. The Amplified IDEIA HpStAR kit is therefore the most sensitive and specific of the three tests that are available for pre-treatment, non-invasive detection of H. pylori in stool samples in an English adult dyspeptic population.
Collapse
Affiliation(s)
- Stephanie A Chisholm
- Specialist and Reference Microbiology Division, 61 Colindale Avenue, Colindale, London NW9 5HT, UK 2Chelmsford Microbiology Laboratory, Chelmsford, UK 3Broomfield Hospital, Chelmsford, UK
| | - Claire L Watson
- Specialist and Reference Microbiology Division, 61 Colindale Avenue, Colindale, London NW9 5HT, UK 2Chelmsford Microbiology Laboratory, Chelmsford, UK 3Broomfield Hospital, Chelmsford, UK
| | - E Louise Teare
- Specialist and Reference Microbiology Division, 61 Colindale Avenue, Colindale, London NW9 5HT, UK 2Chelmsford Microbiology Laboratory, Chelmsford, UK 3Broomfield Hospital, Chelmsford, UK
| | - Seth Saverymuttu
- Specialist and Reference Microbiology Division, 61 Colindale Avenue, Colindale, London NW9 5HT, UK 2Chelmsford Microbiology Laboratory, Chelmsford, UK 3Broomfield Hospital, Chelmsford, UK
| | - Robert J Owen
- Specialist and Reference Microbiology Division, 61 Colindale Avenue, Colindale, London NW9 5HT, UK 2Chelmsford Microbiology Laboratory, Chelmsford, UK 3Broomfield Hospital, Chelmsford, UK
| |
Collapse
|
8
|
Ratiner YA, Salmenlinna S, Eklund M, Keskimäki M, Siitonen A. Serology and genetics of the flagellar antigen of Escherichia coli O157:H7a,7c. J Clin Microbiol 2003; 41:1033-40. [PMID: 12624026 PMCID: PMC150270 DOI: 10.1128/jcm.41.3.1033-1040.2003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2002] [Revised: 09/03/2002] [Accepted: 11/23/2002] [Indexed: 11/20/2022] Open
Abstract
Among Escherichia coli strains of the O55:H7 serovar, which is considered the ancestor of Shiga toxin-producing E. coli (STEC) O157:H7, two subtypes, H7a,7b and H7a,7c (briefly, H7a,b and H7a,c, respectively), of the H7 flagellar antigen have been described previously [J. Wright and R. Villanueva, J. Hyg. (Camb.) 51:39-48, 1953; Y. A. Ratiner and V. A. Sinelnikova, Zh. Microbiol. Epidemiol. Immunobiol. 3:111-116, 1969). We have now studied 13 STEC O157:H7 strains and 1 O55:H7 strain that were epidemiologically unrelated, that originated from six countries on two continents, and that had different profiles when analyzed by multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and PCR for stx and eae. They were all found to possess the H7a,c flagellar antigen. Serum cross-absorption assays confirmed that their H antigens were indistinguishable from each other and from that of E. coli O55:H7a,c but differed from the standard H7a,b antigen of E. coli H test strain U5/41. It was shown by phage-mediated transduction that the flagellin genes for these two H-antigen subserotypes were alleles of the E. coli fliC locus. On the basis of the serological data obtained in this study and the molecular characteristics of E. coli fliC(H7) alleles recently published, it is inferred that H7a,c and H7a,b are the main serological subtypes of the group of E. coli H7 flagellins.
Collapse
Affiliation(s)
- Yuli A Ratiner
- Mechnikov Research Institute for Vaccines and Sera of Russian Academy of Medical Science, Moscow, Russia
| | | | | | | | | |
Collapse
|
9
|
WATANABE K, ARAKAWA H, MAEDA M. Analytical Chemistry related to Biofunctional Research. Rapid simultaneous detection of verotoxin 1 and 2 using time-resolved fluoroimmunoassay. BUNSEKI KAGAKU 2002. [DOI: 10.2116/bunsekikagaku.51.381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Affiliation(s)
- Kazuyuki WATANABE
- School of Pharmaceutical Sciences, Showa University
- Clinical Laboratory, Showa University Hospital
| | | | - Masako MAEDA
- School of Pharmaceutical Sciences, Showa University
| |
Collapse
|
10
|
Stapp JR, Jelacic S, Yea YL, Klein EJ, Fischer M, Clausen CR, Qin X, Swerdlow DL, Tarr PI. Comparison of Escherichia coli O157:H7 antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures. J Clin Microbiol 2000; 38:3404-6. [PMID: 10970391 PMCID: PMC87394 DOI: 10.1128/jcm.38.9.3404-3406.2000] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We evaluated the Meridian IC-STAT direct fecal and broth culture antigen detection methods with samples from children infected with Escherichia coli O157:H7 and correlated the antigen detection results with the culture results. Stools of 16 children who had recently had stool cultures positive for this pathogen (population A) and 102 children with diarrhea of unknown cause (population B) were tested with the IC-STAT device (direct testing). Fecal broth cultures were also tested with this device (broth testing). The results were correlated to a standard of the combined yield from direct culture of stools on sorbitol-MacConkey (SMAC) agar and culture of broth on SMAC agar. Eleven (69%) of the population A stool specimens yielded E. coli O157:H7 when plated directly on SMAC agar. Two more specimens yielded this pathogen when the broth culture was similarly plated. Of these 13 stool specimens, 8 and 13 were positive by direct and broth testing (respective sensitivities, 62 and 100%). Compared to the sensitivity of a simultaneously performed SMAC agar culture, the sensitivity of direct testing was 73%. Three (3%) of the population B stool specimens contained E. coli O157:H7 on SMAC agar culture; one and three of these stool specimens were positive by direct and broth testing, respectively. The direct and broth IC-STAT tests were 100% specific with samples from children from population B. Direct IC-STAT testing of stools is rapid, easily performed, and specific but is insufficiently sensitive to exclude the possibility of infection with E. coli O157:H7. Performing the IC-STAT test with a broth culture increases its sensitivity. However, attempts to recover E. coli O157:H7 by culture should not be abandoned but, rather, should be increased when the IC-STAT test result is positive.
Collapse
Affiliation(s)
- J R Stapp
- Departments of Laboratory Medicine, Children's Hospital and Regional Medical Center, Seattle, Washington 98105, USA
| | | | | | | | | | | | | | | | | |
Collapse
|